Anika Therapeutics Inc. (ANIK) Ownership

$10.63

$0.07 (-0.65%)
Last update: 06:15 PM EST
Day's range
$10.55
Day's range
$10.7

Anika Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 1.65 M $15.90 M   -5.01% 11.52%
VANGUARD GROUP INC 01/29/2026 779.17 K $7.49 M   -0.19% 5.43%
MORGAN STANLEY 02/13/2026 772.23 K $7.42 M   95.63% 5.38%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 606.54 K $5.82 M   -4.15% 4.22%
BOOTHBAY FUND MANAGEMENT, LLC 02/17/2026 534.51 K $5.14 M   -0.95% 3.72%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 515.72 K $4.96 M   -3.25% 3.59%
CAPITAL MANAGEMENT CORP /VA 02/02/2026 500.47 K $4.81 M   -9.21% 3.48%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 494.32 K $4.75 M   -17.77% 3.44%
STATE STREET CORP 02/13/2026 336.54 K $3.23 M   4.07% 2.34%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 325.52 K $3.13 M   -3.03% 2.27%
TWO SIGMA INVESTMENTS, LP 02/17/2026 233.81 K $2.25 M   192.55% 1.63%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 195.59 K $1.88 M   78.11% 1.36%
TRIGRAN INVESTMENTS, INC. 02/13/2026 168.40 K $1.62 M   -89.61% 1.17%
GOLDMAN SACHS GROUP INC 02/10/2026 164.93 K $1.58 M   153.83% 1.15%
JANE STREET GROUP, LLC 02/12/2026 134.77 K $1.30 M   170.95% 0.94%
TWO SIGMA ADVISERS, LP 02/17/2026 126.48 K $1.22 M   242.93% 0.88%
GSA CAPITAL PARTNERS LLP 02/06/2026 122.06 K $1.17 M   192.41% 0.85%
ENVESTNET ASSET MANAGEMENT INC 02/10/2026 117.90 K $1.13 M   -9.87% 0.82%
NORTHERN TRUST CORP 02/17/2026 111.71 K $1.07 M   -6.22% 0.78%
TREXQUANT INVESTMENT LP 02/17/2026 107.31 K $1.03 M   140.11% 0.75%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 106.30 K $1.02 M   2.34% 0.74%
QUANTINNO CAPITAL MANAGEMENT LP 02/17/2026 101.55 K $975.89 K   73.31% 0.71%
AMERICAN CENTURY COMPANIES INC 02/13/2026 100.32 K $964.09 K   72.54% 0.70%
GLOBEFLEX CAPITAL L P 02/11/2026 87.60 K $841.84 K   0.00% 0.61%
MARSHALL WACE, LLP 02/13/2026 87.19 K $837.88 K   18.26% 0.61%
DEUTSCHE BANK AG\ 02/11/2026 81.29 K $781.20 K   0.00% 0.57%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 72.18 K $693.66 K   372.91% 0.50%
BARCLAYS PLC 02/13/2026 70.51 K $677.56 K   119.82% 0.49%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 69.28 K $665.78 K   40.06% 0.48%
IRONWOOD INVESTMENT MANAGEMENT LLC 02/12/2026 65.61 K $630.51 K   132.68% 0.46%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 59.88 K $575.46 K   30.35% 0.42%
DIKER MANAGEMENT LLC 02/17/2026 58.21 K $559.40 K   2.41% 0.41%
AMERIPRISE FINANCIAL INC 02/17/2026 53.24 K $511.64 K   61.39% 0.37%
NUVEEN, LLC 02/12/2026 53.20 K $511.27 K   75.17% 0.37%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 52.99 K $509.27 K   0.00% 0.37%
02/03/2026 50.40 K $484.36 K   100.00% 0.35%
STATE OF WISCONSIN INVESTMENT BOARD 02/17/2026 49.60 K $476.62 K   5.49% 0.35%
BANK OF AMERICA CORP /DE/ 02/17/2026 48.30 K $464.17 K   62.73% 0.34%
ADVYZON INVESTMENT MANAGEMENT, LLC 02/13/2026 48.30 K $464.13 K   139.85% 0.34%
CITADEL ADVISORS LLC 02/17/2026 47.07 K $452.31 K   142.82% 0.33%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 01/22/2026 46.38 K $445.69 K   -3.20% 0.32%
QUADRATURE CAPITAL LTD 02/17/2026 44.74 K $429.90 K   100.00% 0.31%
R SQUARED LTD 01/30/2026 41.58 K $399.59 K   141.67% 0.29%
BANK OF NEW YORK MELLON CORP 02/10/2026 40.51 K $389.25 K   -19.14% 0.28%
ENGINEERS GATE MANAGER LP 02/17/2026 40.28 K $387.05 K   66.94% 0.28%
JPMORGAN CHASE & CO 02/11/2026 33.33 K $320.34 K   24.09% 0.23%
CI PRIVATE WEALTH, LLC 02/19/2026 32.22 K $309.67 K   4.28% 0.22%
CERITY PARTNERS LLC 02/11/2026 31.78 K $305.36 K   5.22% 0.22%
OBJECTIVITY SQUARED, LLC 02/02/2026 31.58 K $303.44 K   100.00% 0.22%
UBS GROUP AG 01/29/2026 28.55 K $274.32 K   -0.83% 0.20%

Anika Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 165 institutional investors and hedge funds held shares of Anika Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 1.65 M

VANGUARD GROUP INC: 779,165

MORGAN STANLEY: 772,230

ACADIAN ASSET MANAGEMENT LLC: 606,544

RENAISSANCE TECHNOLOGIES LLC: 515,717

CAPITAL MANAGEMENT CORP /VA: 500,465

84.28% of Anika Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 13.73 M shares in the last 24 months. This purchase volume represents approximately $145.91 M in transactions.